ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for VANFLYTA:Daiichi Sankyo (Schweiz) AG
Complete information for professionalsDDDÄnderungen anzeigenPrint 
Composition.Galenic FormIndication.UsageContra IndicationWarning restrictions.Interactions.Pregnancy
Driving abilityUnwanted effectsOverdoseEffectsPharm.kinetikPreclinicalOther adviceSwissmedic-Nr.
PackagesRegistration ownerLast update of information 

Zusammensetzung

Wirkstoffe
Quizartinibum (ut quizartinibi dihydrochloridum)
Hilfsstoffe
VANFLYTA 17.7 mg Filmtabletten
Tablettenkern: Hydroxypropylbetadexum, cellulosum microcristallinum (E460), magnesii stearas.
Filmüberzug: Hypromellosum (E464), talcum (E553b), triacetinum (E1518), titanii dioxidum (E171).
VANFLYTA 26.5 mg Filmtabletten
Tablettenkern: Hydroxypropylbetadexum, cellulosum microcristallinum (E460), magnesii stearas.
Filmüberzug: Hypromellosum (E464), talcum (E553b), triacetinum (E1518), titanii dioxidum (E171), ferri oxidum flavum (E172).

2025 ©ywesee GmbH
Settings | Help | Login | Contact | Home